Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

"Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome" - Juurmaa, Menke et al. 2016

We are pleased to announce the publication of a paper in the journal Brain and Behaviour, on which Dr Charlie Stagg is an author.

This paper is available online here.

The paper studied a permanent Parkinsonian syndrome that occurs in intravenous abusers of the designer psychostimulant methcathinone (ephedrone). It is attributed to deposition of contaminant manganese, as reflected by characteristic globus pallidus hyperintensity on T1-weighted MRI.